Copyright Reports & Markets. All rights reserved.

Global Peptide Vaccine Market Research Report 2018 by Manufacturers, Regions, Types and Applications

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Peptide Vaccine Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance
      • 2.1.1 Product Type Market Performance (Volume)
      • 2.1.2 Product Type Market Performance (Value)
    • 2.2 China Peptide Vaccine Market Performance
    • 2.3 USA Peptide Vaccine Market Performance
    • 2.4 Europe Peptide Vaccine Market Performance
    • 2.5 Japan Peptide Vaccine Market Performance
    • 2.6 Korea Peptide Vaccine Market Performance
    • 2.7 India Peptide Vaccine Market Performance
    • 2.8 Southeast Asia Peptide Vaccine Market Performance
    • 2.9 South America Peptide Vaccine Market Performance

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
    • 3.2 China Peptide Vaccine Market Performance (Volume)
    • 3.3 USA Peptide Vaccine Market Performance (Volume)
    • 3.4 Europe Peptide Vaccine Market Performance (Volume)
    • 3.5 Japan Peptide Vaccine Market Performance (Volume)
    • 3.6 Korea Peptide Vaccine Market Performance (Volume)
    • 3.7 India Peptide Vaccine Market Performance (Volume)
    • 3.8 Southeast Asia Peptide Vaccine Market Performance (Volume)
    • 3.9 South America Peptide Vaccine Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 AFFiRiS
      • 4.1.1 AFFiRiS Profiles
      • 4.1.2 AFFiRiS Product Information
      • 4.1.3 AFFiRiS Peptide Vaccine Business Performance
      • 4.1.4 AFFiRiS Peptide Vaccine Business Development and Market Status
    • 4.2 AlerGenetica
      • 4.2.1 AlerGenetica Profiles
      • 4.2.2 AlerGenetica Product Information
      • 4.2.3 AlerGenetica Peptide Vaccine Business Performance
      • 4.2.4 AlerGenetica Peptide Vaccine Business Development and Market Status
    • 4.3 Anergis
      • 4.3.1 Anergis Profiles
      • 4.3.2 Anergis Product Information
      • 4.3.3 Anergis Peptide Vaccine Business Performance
      • 4.3.4 Anergis Peptide Vaccine Business Development and Market Status
    • 4.4 Antigen Express
      • 4.4.1 Antigen Express Profiles
      • 4.4.2 Antigen Express Product Information
      • 4.4.3 Antigen Express Peptide Vaccine Business Performance
      • 4.4.4 Antigen Express Peptide Vaccine Business Development and Market Status
    • 4.5 Apitope Technology
      • 4.5.1 Apitope Technology Profiles
      • 4.5.2 Apitope Technology Product Information
      • 4.5.3 Apitope Technology Peptide Vaccine Business Performance
      • 4.5.4 Apitope Technology Peptide Vaccine Business Development and Market Status
    • 4.6 Araclon Biotech
      • 4.6.1 Araclon Biotech Profiles
      • 4.6.2 Araclon Biotech Product Information
      • 4.6.3 Araclon Biotech Peptide Vaccine Business Performance
      • 4.6.4 Araclon Biotech Peptide Vaccine Business Development and Market Status
    • 4.7 Artificial Cell Technologies
      • 4.7.1 Artificial Cell Technologies Profiles
      • 4.7.2 Artificial Cell Technologies Product Information
      • 4.7.3 Artificial Cell Technologies Peptide Vaccine Business Performance
      • 4.7.4 Artificial Cell Technologies Peptide Vaccine Business Development and Market Status
    • 4.8 Benovus Bio
      • 4.8.1 Benovus Bio Profiles
      • 4.8.2 Benovus Bio Product Information
      • 4.8.3 Benovus Bio Peptide Vaccine Business Performance
      • 4.8.4 Benovus Bio Peptide Vaccine Business Development and Market Status
    • 4.9 Bionor Pharma
      • 4.9.1 Bionor Pharma Profiles
      • 4.9.2 Bionor Pharma Product Information
      • 4.9.3 Bionor Pharma Peptide Vaccine Business Performance
      • 4.9.4 Bionor Pharma Peptide Vaccine Business Development and Market Status
    • 4.10 Circassia
      • 4.10.1 Circassia Profiles
      • 4.10.2 Circassia Product Information
      • 4.10.3 Circassia Peptide Vaccine Business Performance
      • 4.10.4 Circassia Peptide Vaccine Business Development and Market Status
    • 4.11 Celgene Corporation
    • 4.12 Galena Biopharma
    • 4.13 Anergis
    • 4.14 Antigen Express
    • 4.15 Apitope Technology
    • 4.20 Circassia

    5 Market Performance for Manufacturers

    • 5.1 Global Peptide Vaccine Production (K Units) and Market Share by Manufacturers 2013-2018
    • 5.2 Global Peptide Vaccine Revenue (M USD) and Market Share by Manufacturers 2013-2018
    • 5.3 Global Peptide Vaccine Price (USD/Unit) of Manufacturers 2013-2018
    • 5.4 Global Peptide Vaccine Gross Margin of Manufacturers 2013-2018
    • 5.5 Market Concentration

    6 Global Peptide Vaccine Market Performance (Production Point)

    • 6.1 Global Peptide Vaccine Production (K Units) and Market Share by Regions 2013-2018
    • 6.2 Global Peptide Vaccine Revenue (M USD) and Market Share by Regions 2013-2018
    • 6.3 Global Peptide Vaccine Price (USD/Unit) by Regions 2013-2018
    • 6.4 Global Peptide Vaccine Gross Margin by Regions 2013-2018

    7 Development Trend for Regions (Production Point)

    • 7.1 Global Peptide Vaccine Production (K Units), Revenue (&$B$8&) and Growth Rate 2013-2018
    • 7.2 China Peptide Vaccine Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.3 USA Peptide Vaccine Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.4 Europe Peptide Vaccine Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.5 Japan Peptide Vaccine Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.6 Korea Peptide Vaccine Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.7 India Peptide Vaccine Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.8 Southeast Asia Peptide Vaccine Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.9 South America Peptide Vaccine Production (K Units), Revenue (M USD) and Growth Rate 2013-2018

    8 Global Peptide Vaccine Market Performance (Consumption Point)

    • 8.1 Global Peptide Vaccine Consumption and Market Share by Regions 2013-2018
    • 8.2 Global Peptide Vaccine Consumption Value and Market Share by Regions 2013-2018
    • 8.3 Global Peptide Vaccine Price (USD/Unit) by Regions 2013-2018

    9 Development Trend for Regions (Sales Point)

    • 9.1 Global Peptide Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.2 China Peptide Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.3 USA Peptide Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.4 Europe Peptide Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.5 Japan Peptide Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.6 Korea Peptide Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.7 India Peptide Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.8 Southeast Asia Peptide Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.9 South America Peptide Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018

    10 Upstream Source, Technology and Cost

    • 10.1 Upstream Source
    • 10.2 Technology
    • 10.3 Cost

    11 Channel Analysis

    • 11.1 Market Channel
    • 11.2 Distributors

    12 Consumer Analysis

    • 12.1 Prostate Cancer Industry
    • 12.2 Breast Cancer Industry
    • 12.3 Gastric Cancer Industry
    • 12.4 Lung Cancer Industry

    13 Market Forecast 2019-2024

    • 13.1 Production (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
      • 13.1.1 Global Peptide Vaccine Production (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
      • 13.1.2 Global Peptide Vaccine Production (K Units) and Growth Rate 2019-2024
      • 13.1.3 China Peptide Vaccine Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.4 USA Peptide Vaccine Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.5 Europe Peptide Vaccine Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.6 Japan Peptide Vaccine Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.7 Korea Peptide Vaccine Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.8 India Peptide Vaccine Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.9 Southeast Asia Peptide Vaccine Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.10 South America Peptide Vaccine Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 13.2 Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.1 Global Peptide Vaccine Consumption and Market Share by Regions 2019-2024
      • 13.2.2 Global Peptide Vaccine Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.3 China Peptide Vaccine Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.4 USA Peptide Vaccine Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.5 Europe Peptide Vaccine Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.6 Japan Peptide Vaccine Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.7 Korea Peptide Vaccine Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.8 India Peptide Vaccine Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.9 Southeast Asia Peptide Vaccine Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.10 South America Peptide Vaccine Sales, Sales Value and Growth Rate 2019-2024
    • 13.3 Production (K Units), Revenue (M USD) by Types 2019-2024
      • 13.3.1 Overall Market Performance
      • 13.3.2 Biomarkers Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.3.3 NY-ESO-1 Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 13.4 Sales by Application 2019-2024
      • 13.4.1 Overall Market Performance
      • 13.4.2 Prostate Cancer Sales and and Growth Rate 2019-2024
      • 13.4.3 Breast Cancer Sales and and Growth Rate 2019-2024
      • 13.4.4 Gastric Cancer Sales and and Growth Rate 2019-2024
      • 13.4.5 Lung Cancer Sales and and Growth Rate 2019-2024
    • 13.5 Price (USD/Unit) and Gross Profit
      • 13.5.1 Global Peptide Vaccine Price (USD/Unit) Trend 2019-2024
      • 13.5.2 Global Peptide Vaccine Gross Profit Trend 2019-2024

    14 Conclusion

    Geographically, global Peptide Vaccine market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    AFFiRiS
    AlerGenetica
    Anergis
    Antigen Express
    Apitope Technology
    Araclon Biotech
    Artificial Cell Technologies
    Benovus Bio
    Bionor Pharma
    Circassia
    Celgene Corporation
    Galena Biopharma
    Immatics biotechnologies
    Immune Design
    ImmunoCellular Therapeutics

    On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
    Biomarkers
    NY-ESO-1
    For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Peptide Vaccine for each application, including
    Prostate Cancer
    Breast Cancer
    Gastric Cancer
    Lung Cancer
    Pancreatic Cancer
    Production, consumption, revenue, market share and growth rate are the key targets for Peptide Vaccine from 2013 to 2024 (forecast) in these regions
    China
    USA
    Europe
    Japan
    Korea
    India
    Southeast Asia
    South America

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now